The economics of artificial organs.

Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7802778 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1594 (Electronic) Linking ISSN: 0160564X NLM ISO Abbreviation: Artif Organs Subsets: MEDLINE

Publication: Cambridge, MA : Wiley-Blackwell
Original Publication: Cleveland, International Society for Artificial Organs.

Artificial Organs*/economics; Health Care Costs

Spurred by devoted research and institutional financing, organ replacement therapies have progressed monumentally over the last century. Concomitantly, there has been an escalation in healthcare costs. In an aging society where organ replacement therapy utilization is expected to continue to rise, will society need to rethink the economics of end-stage organ dysfunction management?
(© 2023 International Center for Artificial Organ and Transplantation (ICAOT) and Wiley Periodicals LLC.)

Eggers PW. Medicare's end stage renal disease program. Health Care Financ Rev. 2000;22(1):55-60.
Stoney WS. Evolution of cardiopulmonary bypass. Circulation. 2009;119(21):2844-53. https://doi.org/10.1161/CIRCULATIONAHA.108.830174.
Malchesky PS. Artificial organs and vanishing boundaries. Artif Organs. 2001;25(2):75-88. https://doi.org/10.1046/j.1525-1594.2001.025002075.x.
Globe Newswire. Global tempered glass market to reach $201.7 billion by 2030. Available from: https://www.globenewswire.com/en/news-release/2023/05/04/2661911/0/en/Global-Tempered-Glass-Market-to-Reach-201-7-Billion-by-2030.html.
Tatum R, Wong D, Martins PN, Tchantchaleishvili V. Current status and future directions in the development and optimization of thoracic and abdominal artificial organs. Artif Organs. 2023;47(3):451-8. https://doi.org/10.1111/aor.14458.

Date Created: 20230601 Date Completed: 20230802 Latest Revision: 20230802

20250114

10.1111/aor.14592

37259906